ImageBiopsy Lab and Radiobotics have joined forces to improve the application of artificial intelligence (AI) enabled illness diagnoses in the DACH region for musculoskeletal (MSK), orthopaedic, and trauma use-cases. Musculoskeletal illnesses...
There has been a steady increase in the use of contract manufacturing companies since they play a crucial part in the creation of medications, nutritional supplements, and other pharmaceutical items.
Panolos Bioscience, a biopharmaceutical company focused on the development of multi-specific therapeutics to treat cancer, auto-immune diseases, and rare diseases, has formed a collaboration with Chime Biologics, a CDMO, for the development of...
The global Insulin Syringes Market is on the cusp of substantial growth, with projections indicating an impressive increase of $408.67 million during the period from 2022 to 2026. This growth trajectory is marked by a robust Compound Annual Growth...
Major pharmaceutical companies are increasingly turning to artificial intelligence (AI) to streamline patient selection for clinical trials and reduce the number of participants required, potentially speeding up drug development and saving signifi...
Glenmark Pharmaceuticals announced the sale of a 75% stake in its subsidiary company Glenmark Life Sciences to Nirma for $615 per share, for a total consideration of $5.651.75. With the equity reduction, the Mumbai-based drugmaker would retain...
In 2022, the worldwide antifibrinolytic medicines market is expected to be worth US$ 16.2 billion. In the future, it is predicted to rise to US$ 21.2 billion by 2028, with a compound annual growth rate (CAGR) of 4.5% from 2023 to...
Kezar Life Sciences, Inc, a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune mediated and oncologic disorders, today announced that it entered into a collaboration and license agreement with...
Venus Remedies, based in Chandigarh, announced that it has received marketing authorization from Serbia for two oncology medications, gemcitabine and docetaxel. As a result of this, the business has received 511 marketing approvals for its...
The worldwide antifungal medications market was worth USD 13.81 billion in 2021 and is predicted to grow at a 3.6% CAGR over the forecast period. Increasing high-value investments in the healthcare sector, as well as R&D endeavors by big...
, CDSCO.jpg)
